Olema Oncology Funding: $85M Raised, Series C (2020)
Olema Oncology is based in San Francisco. It has raised $85M in total funding. Latest round: Series C.
Olema Oncology funding overview
Olema Oncology is based in San Francisco. Olema Oncology has raised $85M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series C announced in October 2020. The round record for Olema Oncology runs through 2020; nothing later has been disclosed. Investors on record include Vivo Capital, Avoro Capital Advisors, BlackRock, Deerfield Management Company, OrbiMed, BVF Partners L.P. and 8 others. 14 distinct backers are named across the disclosed rounds.
Olema Oncology at a glance
Total raised
$85M
Latest round
Series C
Latest round date
October 2020
Headquarters
San Francisco
Notable investors
Vivo Capital, Avoro Capital Advisors, BlackRock, Deerfield Management Company, OrbiMed, BVF Partners L.P., Logos Capital, Janus Henderson Investors
Frequently asked about Olema Oncology funding
How much has Olema Oncology raised?
Olema Oncology has raised $85M in total disclosed funding across the rounds on record.
Who has invested in Olema Oncology?
Vivo Capital, Avoro Capital Advisors, BlackRock, Deerfield Management Company, OrbiMed, BVF Partners L.P. are named among the investors backing Olema Oncology.
What was the latest Olema Oncology funding round?
The most recent disclosed round is a Series C, announced in October 2020.
Where is Olema Oncology based?
Olema Oncology is based in San Francisco.
When did Olema Oncology last raise?
The last disclosed Olema Oncology round closed in October 2020 at Series C.
We update the Olema Oncology record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in San Francisco and their backers are listed below.
